{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T17:23:06Z","timestamp":1795022586456,"version":"4.10.1"},"reference-count":32,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"43","license":[{"start":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T00:00:00Z","timestamp":1761264000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,10,24]]},"abstract":"<jats:p>Thyroid cancer (TC) ranks ninth in global incidence and is the most common endocrine malignancy worldwide. Despite their large populations and relatively low proportion of high-income countries, East and Southeast Asia face significant challenges posed by TC. This study aims to evaluate long-term trends and regional differences in the incidence, prevalence, mortality, and disability-adjusted life years (DALYs) of thyroid cancer among women in non-high-income East and Southeast Asia from 1990 to 2021 and examine associations with sociodemographic index (SDI) and high body mass index. Data were obtained from the 2021 Global Burden of Disease database. The burden of TC was stratified by etiology, age, sex, SDI, and geographic region. The average annual percentage change in incidence, prevalence, mortality, and DALYs was calculated. This study used publicly available data from the Global Burden of Disease database. Ethical approval and informed consent were not required because the data are de-identified and publicly accessible, and no individual patient information was used. Across East and Southeast Asia, the incidence, prevalence, deaths, and DALYs of female TC steadily increased, while most countries and territories exhibited decreasing trends in age-standardized mortality rate and age-standardized disability-adjusted life year rate. In non-high-income areas, incidence and prevalence were positively correlated with SDI, whereas mortality and DALY rates were negatively correlated with SDI. DALY rates and mortality attributable to high body mass index were slightly more pronounced among women. The burden of female TC varies by etiology, region, and SDI level. Interventions focused on improving early diagnosis, enhancing healthcare accessibility, and implementing targeted management strategies are critical, especially in low-SDI settings. Addressing obesity is an urgent priority. Standardized diagnostic criteria and strengthened global collaboration are necessary to reduce the TC burden among women in East and Southeast Asia.<\/jats:p>","DOI":"10.1097\/md.0000000000045476","type":"journal-article","created":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T19:00:35Z","timestamp":1761332435000},"page":"e45476","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Burden of thyroid cancer among women in non-high-income East and Southeast Asia, 1990\u20132021: An observational study"],"prefix":"10.1097","volume":"104","author":[{"given":"Jiaolin","family":"Fan","sequence":"first","affiliation":[{"name":"Department of Thyroid Surgery, First Hospital of Shanxi Medical University, Taiyuan, China"},{"name":"First School of Clinical Medicine, Shanxi Medical University, Taiyuan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunan","family":"Zhou","sequence":"additional","affiliation":[{"name":"First School of Clinical Medicine, Shanxi Medical University, Taiyuan, China"},{"name":"Department of Gastroenterology, First Hospital of Shanxi Medical University, Taiyuan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingzhu","family":"Zhao","sequence":"additional","affiliation":[{"name":"First School of Clinical Medicine, Shanxi Medical University, Taiyuan, China"},{"name":"Department of Neurology, The First Hospital of Shanxi Medical University, Taiyuan, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liying","family":"Song","sequence":"additional","affiliation":[{"name":"Department of Thyroid Surgery, First Hospital of Shanxi Medical University, Taiyuan, China"},{"name":"First School of Clinical Medicine, Shanxi Medical University, Taiyuan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuli","family":"Gao","sequence":"additional","affiliation":[{"name":"Department of Thyroid Surgery, First Hospital of Shanxi Medical University, Taiyuan, China"},{"name":"First School of Clinical Medicine, Shanxi Medical University, Taiyuan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7409-9099","authenticated-orcid":false,"given":"Jing","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Thyroid Surgery, First Hospital of Shanxi Medical University, Taiyuan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20261118","first-page":"209","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"key":"R2-20261118","doi-asserted-by":"crossref","first-page":"e208759","DOI":"10.1001\/jamanetworkopen.2020.8759","article-title":"Global burden of thyroid cancer from 1990 to 2017.","volume":"3","author":"Deng","year":"2020","journal-title":"JAMA Network Open"},{"key":"R3-20261118","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1055\/a-1089-7870","article-title":"Updates on the management of thyroid cancer.","volume":"52","author":"Araque","year":"2020","journal-title":"Hormone Metabol Res = Hormon- und Stoffwechselforschung = Hormones et metabolisme"},{"key":"R4-20261118","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.1038\/s41591-022-01990-1","article-title":"The global burden of disease study at 30 years.","volume":"28","author":"Murray","year":"2022","journal-title":"Nat Med"},{"key":"R5-20261118","doi-asserted-by":"crossref","first-page":"2494","DOI":"10.1111\/1759-7714.14099","article-title":"Global burden of thyroid cancer and its attributable risk factors in 204 countries and territories from 1990 to 2019.","volume":"12","author":"Bao","year":"2021","journal-title":"Thoracic Cancer"},{"key":"R6-20261118","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/S2213-8587(22)00035-3","article-title":"The epidemiological landscape of thyroid cancer worldwide: GLOBOCAN estimates for incidence and mortality rates in 2020.","volume":"10","author":"Pizzato","year":"2022","journal-title":"Lancet Diabetes Endocrinol"},{"key":"R7-20261118","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1111\/j.1468-0009.2005.00398.x","article-title":"The epidemiologic transition: a theory of the epidemiology of population change.","volume":"83","author":"Omran","year":"1971","journal-title":"Milbank Q"},{"key":"R8-20261118","doi-asserted-by":"crossref","first-page":"2162","DOI":"10.1016\/S0140-6736(24)00933-4","article-title":"Global burden and strength of evidence for 88 risk factors in 204 countries and 811 subnational locations, 1990\u20132021: a systematic analysis for the global burden of disease study 2021.","volume":"403","author":"Brauer","year":"2024","journal-title":"Lancet"},{"key":"R9-20261118","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1186\/s13045-024-01640-8","article-title":"Global burden of cancer and associated risk factors in 204 countries and territories, 1980\u20132021: a systematic analysis for the GBD 2021.","volume":"17","author":"Wu","year":"2024","journal-title":"J Hematol Oncol"},{"key":"R10-20261118","doi-asserted-by":"crossref","first-page":"2259","DOI":"10.1016\/S0140-6736(24)00769-4","article-title":"Findings from the global burden of disease study 2021.","volume":"403","author":"Murray","year":"2024","journal-title":"Lancet"},{"key":"R11-20261118","doi-asserted-by":"crossref","first-page":"2133","DOI":"10.1016\/S0140-6736(24)00757-8","article-title":"Global incidence, prevalence, Years Lived with Disability (YLDs), disability-adjusted life-years (DALYs), and Healthy Life Expectancy (HALE)for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990\u20132021: a systematic analysis for the global burden of disease study 2021.","volume":"403","author":"Ferrari","year":"2024","journal-title":"Lancet"},{"key":"R12-20261118","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.jhep.2021.04.035","article-title":"Global burden of acute viral hepatitis and its associationwith socioeconomic development status, 1990\u20132019.","volume":"75","author":"Zeng","year":"2021","journal-title":"J Hepatol"},{"key":"R13-20261118","doi-asserted-by":"crossref","first-page":"2204","DOI":"10.1016\/S0140-6736(24)00685-8","article-title":"Burden of disease scenarios for 204 countries and territories, 2022\u20132050: a forecasting analysis for the global burden of disease study 2021.","volume":"403","author":"Emil Vollset","year":"2024","journal-title":"Lancet"},{"key":"R14-20261118","doi-asserted-by":"crossref","first-page":"04084","DOI":"10.7189\/jogh.14.04084","article-title":"Trends and projections of the global burden of thyroid cancer from 1990 to 2030.","volume":"14","author":"Hu","year":"2024","journal-title":"J Global Health"},{"key":"R15-20261118","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1002\/agm2.12277","article-title":"Temporal trends of thyroid cancer between 2010 and 2019 in asian countries by geographical region and sdi, comparison with global data.","volume":"6","author":"Rezaei","year":"2023","journal-title":"Aging Med"},{"key":"R16-20261118","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1089\/thy.2016.0100","article-title":"Systematic review of trends in the incidence rates of thyroid cancer.","volume":"26","author":"Wiltshire","year":"2016","journal-title":"Thyroid"},{"key":"R17-20261118","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2013\/965212","article-title":"Worldwide Increasing incidence of thyroid cancer: update on epidemiology and risk factors.","volume":"2013","author":"Pellegriti","year":"2013","journal-title":"J Cancer Epidemiol"},{"key":"R18-20261118","doi-asserted-by":"crossref","first-page":"102014","DOI":"10.1016\/j.canep.2021.102014","article-title":"Thyroid cancer overdiagnosis revisited.","volume":"74","author":"Zaridze","year":"2021","journal-title":"Cancer Epidemiol"},{"key":"R19-20261118","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1038\/nrendo.2016.110","article-title":"The changing incidence of thyroid cancer.","volume":"12","author":"Kitahara","year":"2016","journal-title":"Nat Rev Endocrinol"},{"key":"R20-20261118","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/S2213-8587(21)00027-9","article-title":"Thyroid cancer incidence trends by histology in 25 countries: a population-based study.","volume":"9","author":"Miranda-Filho","year":"2021","journal-title":"The Lancet Diabetes Endocrinol"},{"key":"R21-20261118","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1038\/s41574-019-0263-x","article-title":"Geographic influences in the global rise of thyroid cancer.","volume":"16","author":"Kim","year":"2019","journal-title":"Nat Rev Endocrinol"},{"key":"R22-20261118","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1016\/S0140-6736(23)00020-X","article-title":"Thyroid cancer.","volume":"401","author":"Chen","year":"2023","journal-title":"The Lancet"},{"key":"R23-20261118","doi-asserted-by":"crossref","first-page":"204201882210900","DOI":"10.1177\/20420188221090012","article-title":"The global burden of thyroid cancer in high-income Asia-Pacific: a systematic analysis of the global burden of disease study.","volume":"13","author":"Li","year":"2022","journal-title":"Therap Adv Endocrinol Metabol"},{"key":"R24-20261118","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1080\/00324720308088","article-title":"The fertility impact of changes in the timing of childbearing in the developing world.","volume":"53","author":"Bongaarts","year":"1999","journal-title":"Population Stud"},{"key":"R25-20261118","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1007\/s12020-023-03408-5","article-title":"Survival rate of Thyroid Cancer in the Asian countries: a Systematic Review and meta-analysis Study.","volume":"82","author":"Hassanipour","year":"2023","journal-title":"Endocrine"},{"key":"R26-20261118","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1186\/s12885-021-08023-z","article-title":"Trends in incidence and histological pattern of thyroid cancer in Ho Chi Minh City, Vietnam (1996\u20132015): a population-based Study.","volume":"21","author":"Pham","year":"2021","journal-title":"BMC Cancer"},{"key":"R27-20261118","doi-asserted-by":"crossref","first-page":"3581","DOI":"10.1017\/S1368980020002384","article-title":"Iodine nutrition status in Africa: potentiallyhigh prevalence of iodine deficiency in pregnancy even in countries classified as iodine sufficient.","volume":"24","author":"Businge","year":"2020","journal-title":"Public Health Nutr"},{"key":"R28-20261118","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1093\/inthealth\/ihy044","article-title":"Determinants of health care utilisation: the caseof timor-leste.","volume":"10","author":"Guinness","year":"2018","journal-title":"Int Health"},{"key":"R29-20261118","doi-asserted-by":"crossref","first-page":"707233","DOI":"10.3389\/fendo.2021.707233","article-title":"Secular trends in the epidemiologic patterns of thyroid cancer in China over three decades: an updated systematic analysis of global burden of disease study 2019 data.","volume":"12","author":"Li","year":"2021","journal-title":"Front Endocrinol"},{"key":"R30-20261118","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1186\/s13045-024-01593-y","article-title":"Global burden of thyroid cancer from 1990 to 2021: a systematic analysis from the global burden of disease study 2021.","volume":"17","author":"Zhou","year":"2024","journal-title":"J Hematol Oncol"},{"key":"R31-20261118","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1111\/obr.12070","article-title":"Obesity and thyroid cancer: epidemiologic associations and underlying mechanisms.","volume":"14","author":"Pazaitou-Panayiotou","year":"2013","journal-title":"Obesity Rev"},{"key":"R32-20261118","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1089\/thy.2013.0232","article-title":"Obesity and thyroid cancer: a clinical update.","volume":"24","author":"Pappa","year":"2014","journal-title":"Thyroid"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000045476","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T17:00:22Z","timestamp":1795021222000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000045476"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,24]]},"references-count":32,"journal-issue":{"issue":"43","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000045476","relation":{},"ISSN":["1536-5964","0025-7974"],"issn-type":[{"value":"1536-5964","type":"electronic"},{"value":"0025-7974","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10,24]]},"assertion":[{"value":"2025-08-18","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-09-30","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}